Sorafenib is an active ingredient in the original anticancer drug Nexavar. Included in the group of protein kinase inhibitors. Sorafenib inhibits the development of tumor cells. The drug was first released in Germany by the pharmaceutical company Bayer AG. The pills were expensive and out of reach for most patients with tumors.